Literature DB >> 19527847

Management of shunt dysfunction in the era of TIPS endografts.

Timothy W I Clark1.   

Abstract

Significantly improved long-term patency can be achieved with transjugular intrahepatic portosystemic shunt (TIPS) endografts compared to conventional bare stents. In the USA, approximately 80% of TIPS procedures are performed using these devices. The phenomenon of early shunt thrombosis with TIPS created with bare stent TIPS, attributed to biliary fistulae, is seldom observed in patients with TIPS endografts. Intrashunt stenoses within the polytetrafluoroethylene-lined conduit are also rare. However, as with shunts created with bare stents, distinct patterns of dysfunction can occur with TIPS endografts. Some of these are inherent to the learning curve of placing these devices and others are secondary to device design. The interventional radiologist needs to be aware of these patterns of shunt dysfunction and have a systematic approach to their management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19527847     DOI: 10.1053/j.tvir.2009.04.003

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  8 in total

Review 1.  Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Authors:  Paul V Suhocki; Matthew P Lungren; Baljendra Kapoor; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.

Authors:  Hauke S Heinzow; Philipp Lenz; Michael Köhler; Frank Reinecke; Hansjörg Ullerich; Wolfram Domschke; Dirk Domagk; Tobias Meister
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

3.  Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.

Authors:  Xuefeng Luo; Ming Zhao; Xiaoze Wang; Mingshan Jiang; Jiaze Yu; Xiao Li; Li Yang
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

4.  A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination.

Authors:  Jiacheng Liu; Jie Meng; Chen Zhou; Qin Shi; Chongtu Yang; Jinqiang Ma; Manman Chen; Bin Xiong
Journal:  J Interv Med       Date:  2020-10-13

5.  Quantitative analysis of in-TIPS thrombosis in abdominal CT.

Authors:  Simon Bernatz; Inga Weitkamp; Jan-Erik Scholtz; Vitali Koch; Leon D Grünewald; Christoph Mader; Jörg Ackermann; Moritz H Albrecht; Simon S Martin; Thomas J Vogl; Scherwin Mahmoudi
Journal:  Eur J Radiol Open       Date:  2022-02-23

6.  Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.

Authors:  Younes Jahangiri; Timothy Kerrigan; Lei Li; Dominik Prosser; Anantnoor Brar; Johnathan Righetti; Ryan C Schenning; John A Kaufman; Khashayar Farsad
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

7.  MRI-monitored intra-shunt local agent delivery of motexafin gadolinium: towards improving long-term patency of TIPS.

Authors:  Han Wang; Feng Zhang; Yanfeng Meng; Tong Zhang; Patrick Willis; Thomas Le; Stephanie Soriano; Erik Ray; Karim Valji; Guixiang Zhang; Xiaoming Yang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Authors:  Dengke Teng; Hao Zuo; Lin Liu; Jinghui Dong; Lei Ding
Journal:  Virol J       Date:  2018-10-01       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.